AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18447219
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Smecta (Control)
Trial: 18447219
Drug: Drug-separated moxibustion
RxNorm normalized name: serrated swimming crab, cooked preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-separated moxibustion at Shenque (CV 8)
Trial: 8897357
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin (PCN) administered at a dose of 1,200,000 u, intramuscularly at 3-week intervals for at least one year.
Trial: 1677774
Drug: Lorazepam (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (4.5 mg)
Trial: 6647190
Drug: Metronidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (500 mg)
Trial: 10150324
Drug: Cefoxitin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (1 g)
Trial: 27676664
Drug: Pulsed dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed dose radiofrequency followed by continuous thermal radiofrequency ablation
Trial: 18554712
Drug: LT-patch (37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LT-patch (37.5 mug of heat-labile toxin from E. coli)
Trial: 2146370
Drug: resection and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: resection and continuous hepatic artery infusion (CHAI) of fluorodeoxyuridine (FUdR) in arm A2
Trial: 1032070
Drug: Buprenorphine (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.15 mg and 0.3 mg)
Trial: 1032070
Drug: Buprenorphine (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.6 mg and 1.2 mg)
Trial: 7628027
Drug: Morphine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (150 micrograms.kg‐1)
Trial: 28353611
Drug: Intra-articular lumbar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular lumbar facet joint corticosteroid injection (ICI)
Trial: 25393089
Drug: Systemic steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic steroid therapy
Trial: 29797981
Drug: Steroid combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid combined with dehydrant therapy
Trial: 22424787
Drug: Oxytocin (24IU)
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin (24IU) administered in the second session
Trial: 11782325
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of racemic methadone (initial doses of 3 to 6 mg followed by 6 to 12 mg over 24 hr)
Trial: 9633672
Drug: 100-g TFD
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-g TFD (tryptophan-free amino acid drink)
Trial: 7866680
Drug: Insulin hypoglycaemia
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin hypoglycaemia (IH) test
Trial: 1967919
Drug: Terfenadine, 60
RxNorm normalized name: Terfenadine, 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine, 60 mg BID
Trial: 23680127
Drug: ABThera Open
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABThera Open Abdomen Negative Pressure Therapy System
Trial: 9493805
Drug: MEDI‐493 (palivizumab)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI‐493 (palivizumab) 3 mg/kg
Trial: 9493805
Drug: MEDI‐493 (palivizumab)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI‐493 (palivizumab) 10 mg/kg
Trial: 9493805
Drug: MEDI‐493 (palivizumab)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI‐493 (palivizumab) 15 mg/kg
Trial: 2528256
Drug: 20% azelaic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% azelaic acid cream
Trial: 60566
Drug: Timolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (10 mg thrice daily)
Trial: 28835400
Drug: Vertebral angioplasty/stenting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vertebral angioplasty/stenting plus best medical treatment (BMT)
Trial: 23800627
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein formula (HP: 2.05 and 3.2 g/100 mL)
Trial: 23800627
Drug: Lower protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower protein formula (LP: 1.25 and 1.6 g/100 mL)
Trial: 11246738
Drug: Various interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Various interventions in phase 3 trials for urinary bladder cancer therapy
Trial: 2697239
Drug: Lidocaine 100
RxNorm normalized name: lidocaine 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 100 mg
Trial: 7954529
Drug: Intrapleural OK-432
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural OK-432 injection
Trial: 7954529
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no intrapleural OK-432 injection)
Trial: 2888424
Drug: Terfenadine 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 180 mg
Trial: 29452584
Drug: P1000/Ca1000 (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P1000/Ca1000 (1000 mg/d phosphorus and 1000 mg/d calcium)
Trial: 27151156
Drug: UC-no additional
RxNorm normalized name: Astri-UC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UC-no additional therapy.
Trial: 10867764
Drug: Transmyocardial revascularization
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TRANSENDOCARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transmyocardial revascularization (TMR) as an adjunct to coronary artery bypass grafting (CABG)
Trial: 3966424
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc supplements
Trial: 13130174
Drug: 30-45 min
RxNorm normalized name: salmeterol
DrugBank: Salmeterol (DB00938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 30-45 min of physiotherapy twice daily
Trial: 1519783
Drug: Epidural clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural clonidine (8 micrograms.kg‐1 in 4 ml over 2 min)
Trial: 1519783
Drug: Intravenous clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous clonidine (8 micrograms.kg‐1 in 10 ml over 14 min)
Trial: 20305057
Drug: Biolimus A9
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Biolimus A9 (BA9) at doses from 0.0075 mg/kg to 0.25 mg/kg
Trial: 19930788
Drug: Azelastine 0.15%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 0.15% and 0.10% nasal sprays
Trial: 2442536
Drug: Bornaprolol 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bornaprolol 80 mg
Trial: 2442536
Drug: Bornaprolol 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bornaprolol 120 mg
Trial: 2442536
Drug: Bornaprolol 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bornaprolol 240 mg
Trial: 2442536
Drug: Bornaprolol 480
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bornaprolol 480 mg
Trial: 2442536
Drug: Bornaprolol 960
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bornaprolol 960 mg
Trial: 2442536
Drug: Bornaprolol (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bornaprolol (various doses)
Trial: 29807824
Drug: 1·1 GBq
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1·1 GBq radioactive iodine after thyroid hormone withdrawal
Trial: 29807824
Drug: 3·7 GBq
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3·7 GBq radioactive iodine after thyroid hormone withdrawal
Trial: 25019111
Drug: Analgesic (only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic (only if required)
Trial: 1286495
Drug: Flumazenil (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.7 mg, intravenously)
Trial: 4023558
Drug: Praziquantel therapy
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel therapy
Trial: 30475957
Drug: Continuous Calorie
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Calorie Restriction (CCR) - daily energy deficit ∼20%
Trial: 28749419
Drug: 28 g
RxNorm normalized name: SM Syringe 28 g, 0.5cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 28 g of whole, lightly salted roasted almonds
Trial: 26785372
Drug: BCAA +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA + OA supplementation (16 g BCAA and 12 g OA)
Trial: 10823258
Drug: Weekly self-testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly self-testing and self-dosing
Trial: 9059217
Drug: Midazolam 0.1
RxNorm normalized name: midazolam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.1 mg kg‐1
Trial: 1287614
Drug: Cefaclor 500
RxNorm normalized name: cefaclor 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor 500 mg three times daily
Trial: 6337988
Drug: Amoxycillin 500
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 500 mg three times daily
Trial: 31413542
Drug: Amlodipine 2.5‐5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 2.5‐5 mg/day
Trial: 16985182
Drug: Regimen C
RxNorm normalized name: ASPIRIN 81 mg ORAL TABLET, CHEWABLE [Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen C (high-intensity therapy with higher doses of doxorubicin, cyclophosphamide, and ifosfamide)
Trial: 16985182
Drug: Increasing exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing exposure to ifosfamide (90 to 140 g/m2), cyclophosphamide (9.6 to 17.6 g/m2), and doxorubicin (375 to 450 mg/m2)
Trial: 16358235
Drug: Cefotaxime-heparin lock
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime-heparin lock solution
Trial: 12028163
Drug: Geriatric Evaluation
RxNorm normalized name: CATHETER,EXTERNAL CONVEEN #5120 GERIATRIC/PEDIATRIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Geriatric Evaluation and Management Unit (GEMU) treatment
Trial: 12028163
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (traditional treatment in Department of Internal Medicine)
Trial: 9145823
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg od for 10 days
Trial: 9145823
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg bd for 10 days
Trial: 29204924
Drug: Bleomycin microneedle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleomycin microneedle patch
Trial: 26944837
Drug: Short-acting β-agonists
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting β-agonists
Trial: 25509976
Drug: Intracervical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical anesthesia (10 ml %2 prilocaine)
Trial: 19469296
Drug: Morphine 0.5
RxNorm normalized name: morphine 0.5 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.5 mg/ml + placebo (M-group)
Trial: 12522747
Drug: Linezolid (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (600 mg intravenously or orally every 12 h)
Trial: 8681490
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum (2 mg nicotine per piece, at least six pieces per day)
Trial: 1947721
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion without volume expansion
Trial: 1947721
Drug: Control (Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Day B: no insulin and glucose infusion)
Trial: 27128612
Drug: MF 800 µg
RxNorm normalized name: hyaluronidase
DrugBank: Hyaluronidase (DB14740)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MF 800 µg + F 20 µg coadministered (MF + F)
Trial: 20702114
Drug: Candesartan (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (4 mg/day)
Trial: 17130203
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg/day)
Trial: 17211270
Drug: Dalteparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (5000 U) given subcutaneously once daily for 6 weeks postoperatively
Trial: 12210616
Drug: Network meta-analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Network meta-analysis techniques for treatment comparisons
Trial: 273143
Drug: Overall (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall (both intrathecal chemotherapy groups)
Trial: 25195547
Drug: n-3 fish
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fish oil 3000 mg/day
Trial: 21892200
Drug: Antofloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antofloxacin (400 mg on day 1 and 200 mg on days 2 to 5)
Trial: 306577
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole
Trial: 19515236
Drug: Both oral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both oral and vaginal metronidazole
Trial: 28544992
Drug: USL261 (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: USL261 (both doses)
Trial: 19156515
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin (PLD) 40 mg/m² every 4 weeks for 6-9 cycles and weekly trastuzumab (4 mg/kg loading dose, then 2 mg/kg)
Trial: 11465562
Drug: Alfentanil at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil at a plasma concentration of 100 ng/ml
Trial: 7997427
Drug: Maintenance dose
RxNorm normalized name: Firmagon 80mg Powder for Injection Maintenance Dose Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance dose of digoxin administered at 24‐h intervals for 7 days (study group, n = 15)
Trial: 3375576
Drug: 405 mg
RxNorm normalized name: olanzapine 405 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 405 mg elemental calcium as a salt linked to an amino acid precursor
Trial: 3375576
Drug: 405 mg
RxNorm normalized name: olanzapine 405 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 405 mg CaC12
Trial: 3375576
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg Ca as Ca gluconolactate and carbonate
Trial: 30899530
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 µg/day)
Trial: 17391168
Drug: Metformin 1
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1 g twice daily
Trial: 14674490
Drug: Microabrasion slurry
RxNorm normalized name: SEA SALT 15 g in 100 g / SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL 15 g in 100 g TOPICAL GRANULE [GZE MICRODERMABRASION SCRUB]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microabrasion slurry (Opalustre) for 20 seconds with a load of 200 g
Trial: 14674490
Drug: Abrasive cleaning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrasive cleaning paste (Pell-ex) for 20 seconds with a load of 200 g
Trial: 19508590
Drug: Norepinephrine (NE)
DrugBank: Norepinephrine (DB00368)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norepinephrine (NE) infusion
Trial: 3481814
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (ANG II) infusion
Trial: 8203510
Drug: Guanadrel (G)
RxNorm normalized name: GUANADREL
DrugBank: Guanadrel (DB00226)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guanadrel (G) to suppress SNS activity
Trial: 20673244
Drug: Patient-physician agreement
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-physician agreement on final decisions to take medication
Trial: 11457560
Drug: TAB9 (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAB9 (0.2 mg)
Trial: 11457560
Drug: TAB9 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAB9 (1 mg)
Trial: 11457560
Drug: TAB9 (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAB9 (0.2 mg and 1 mg)
Trial: 31485880
Drug: Group spiritual
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group spiritual therapy (8 sessions, 45-60 minutes each, twice a week)
Trial: 30389671
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor (PPI) prescriptions (control)
Trial: 21457392
Drug: Oral tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tranexamic acid (TA) treatment (750 mg/d for 4 weeks)
Trial: 21457392
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral tranexamic acid treatment (Control)
Trial: 19042105
Drug: Olanzapine or
RxNorm normalized name: olanzapine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine or risperidone treatment after 16 weeks
Trial: 19042105
Drug: Baseline (drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline (drug naive)
Trial: 19644851
Drug: Low-dose D-penicillamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose D-penicillamine
Trial: 19644851
Drug: High-dose D-penicillamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose D-penicillamine
Trial: 10522184
Drug: Implant-retained overdenture
RxNorm normalized name: betaine
DrugBank: Betaine (DB06756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Implant-retained overdenture (IRO-group, 2 endosseous implants)
Trial: 8471413
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg)
Trial: 23585009
Drug: Ibutilide 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide 1 mg (repeated if AF/AFL not converted after 10 min)
Trial: 23585009
Drug: Propafenone 70
RxNorm normalized name: propafenone 70 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 70 mg (repeated if AF/AFL persisted after 10 min)
Trial: 15579760
Drug: Pioglitazone (≤45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (≤45 mg/d)
Trial: 15579760
Drug: Metformin (≤850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (≤850 mg, three times daily)
Trial: 19496943
Drug: Intraduodenal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraduodenal administration of 1 mg Ac min(‐1) with varying caloric densities (0.75/1.5/3 kcal min(‐1)) in a 200 mL meal.
Trial: 15103751
Drug: Methylprednisolone (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (single dose prior to cardiopulmonary bypass)
Trial: 12842524
Drug: No steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No steroid treatment (control group)
Trial: 9620251
Drug: Radiotherapy (hypofractionation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy (hypofractionation, 5 Gy for fraction, 3-5 doses in one week)
Trial: 9620251
Drug: Radiotherapy (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy (total dose lower than 34 Gy)
Trial: 2223424
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg of zopiclone
Trial: 2195102
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg of triazolam
Trial: 7971743
Drug: Hypnotic-ethanol combinations
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic-ethanol combinations
Trial: 7971743
Drug: Single drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drug intake
Trial: 4458774
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three preparations
Trial: 23218588
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus iscador
Trial: 16443892
Drug: Intensive lifestyle
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive lifestyle therapy
Trial: 23681085
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (500 mg/day)
Trial: 19735181
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g n-3 PUFAs
Trial: 15108768
Drug: Azathioprine (AZA)
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine (AZA) 2 mg/kg/d
Trial: 9112067
Drug: Magnesium pyridoxal-5'-phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium pyridoxal-5'-phosphate glutamate (MPPG) 600 mg daily for 8 weeks
Trial: 20629109
Drug: Gut-specific nutrients
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gut-specific nutrients (GSNs) administered for 1 month